nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Nadolol—ADRB3—polycystic ovary syndrome	0.0178	0.725	CrCbGaD
Treprostinil—CYP2C9—urine—polycystic ovary syndrome	0.0166	0.136	CbGeAlD
Treprostinil—PPARD—adipose tissue—polycystic ovary syndrome	0.0129	0.106	CbGeAlD
Treprostinil—P2RY12—endocrine gland—polycystic ovary syndrome	0.0121	0.0988	CbGeAlD
Treprostinil—PPARD—adrenal gland—polycystic ovary syndrome	0.0116	0.0947	CbGeAlD
Treprostinil—PPARD—female gonad—polycystic ovary syndrome	0.0108	0.0883	CbGeAlD
Treprostinil—PPARD—vagina—polycystic ovary syndrome	0.0107	0.0877	CbGeAlD
Treprostinil—PPARD—endocrine gland—polycystic ovary syndrome	0.01	0.0821	CbGeAlD
Treprostinil—PTGIR—adipose tissue—polycystic ovary syndrome	0.00989	0.081	CbGeAlD
Treprostinil—PTGIR—adrenal gland—polycystic ovary syndrome	0.00887	0.0727	CbGeAlD
Treprostinil—PTGIR—female gonad—polycystic ovary syndrome	0.00827	0.0678	CbGeAlD
Treprostinil—PTGIR—endocrine gland—polycystic ovary syndrome	0.00769	0.063	CbGeAlD
Treprostinil—Contusion—Metformin—polycystic ovary syndrome	0.00726	0.0689	CcSEcCtD
Treprostinil—Nadolol—ADRB2—polycystic ovary syndrome	0.00676	0.276	CrCbGaD
Treprostinil—Pain in extremity—Metformin—polycystic ovary syndrome	0.0046	0.0436	CcSEcCtD
Treprostinil—Dehydration—Metformin—polycystic ovary syndrome	0.00428	0.0406	CcSEcCtD
Treprostinil—Influenza—Metformin—polycystic ovary syndrome	0.00398	0.0377	CcSEcCtD
Treprostinil—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00381	0.0362	CcSEcCtD
Treprostinil—Bradycardia—Metformin—polycystic ovary syndrome	0.00324	0.0307	CcSEcCtD
Treprostinil—Rhinitis—Metformin—polycystic ovary syndrome	0.00319	0.0303	CcSEcCtD
Treprostinil—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00313	0.0297	CcSEcCtD
Treprostinil—Flushing—Metformin—polycystic ovary syndrome	0.00295	0.028	CcSEcCtD
Treprostinil—Erythema—Metformin—polycystic ovary syndrome	0.00277	0.0263	CcSEcCtD
Treprostinil—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00275	0.0225	CbGeAlD
Treprostinil—Muscle spasms—Metformin—polycystic ovary syndrome	0.00266	0.0253	CcSEcCtD
Treprostinil—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00257	0.0244	CcSEcCtD
Treprostinil—Malaise—Metformin—polycystic ovary syndrome	0.0025	0.0237	CcSEcCtD
Treprostinil—Syncope—Metformin—polycystic ovary syndrome	0.00248	0.0236	CcSEcCtD
Treprostinil—Palpitations—Metformin—polycystic ovary syndrome	0.00245	0.0232	CcSEcCtD
Treprostinil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00243	0.0231	CcSEcCtD
Treprostinil—Myalgia—Metformin—polycystic ovary syndrome	0.00236	0.0224	CcSEcCtD
Treprostinil—Chest pain—Metformin—polycystic ovary syndrome	0.00236	0.0224	CcSEcCtD
Treprostinil—Discomfort—Metformin—polycystic ovary syndrome	0.00233	0.0221	CcSEcCtD
Treprostinil—Oedema—Metformin—polycystic ovary syndrome	0.00226	0.0215	CcSEcCtD
Treprostinil—Infection—Metformin—polycystic ovary syndrome	0.00225	0.0213	CcSEcCtD
Treprostinil—Shock—Metformin—polycystic ovary syndrome	0.00222	0.0211	CcSEcCtD
Treprostinil—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00221	0.021	CcSEcCtD
Treprostinil—Anorexia—Metformin—polycystic ovary syndrome	0.00216	0.0204	CcSEcCtD
Treprostinil—Hypotension—Metformin—polycystic ovary syndrome	0.00211	0.02	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00206	0.0195	CcSEcCtD
Treprostinil—Paraesthesia—Metformin—polycystic ovary syndrome	0.00203	0.0193	CcSEcCtD
Treprostinil—Dyspnoea—Metformin—polycystic ovary syndrome	0.00202	0.0191	CcSEcCtD
Treprostinil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00199	0.0189	CcSEcCtD
Treprostinil—Decreased appetite—Metformin—polycystic ovary syndrome	0.00197	0.0186	CcSEcCtD
Treprostinil—Fatigue—Metformin—polycystic ovary syndrome	0.00195	0.0185	CcSEcCtD
Treprostinil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00186	0.0177	CcSEcCtD
Treprostinil—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00185	0.0175	CcSEcCtD
Treprostinil—Abdominal pain—Metformin—polycystic ovary syndrome	0.00179	0.017	CcSEcCtD
Treprostinil—Asthenia—Metformin—polycystic ovary syndrome	0.00162	0.0154	CcSEcCtD
Treprostinil—Pruritus—Metformin—polycystic ovary syndrome	0.0016	0.0152	CcSEcCtD
Treprostinil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00155	0.0147	CcSEcCtD
Treprostinil—Dizziness—Metformin—polycystic ovary syndrome	0.0015	0.0142	CcSEcCtD
Treprostinil—Vomiting—Metformin—polycystic ovary syndrome	0.00144	0.0136	CcSEcCtD
Treprostinil—Rash—Metformin—polycystic ovary syndrome	0.00143	0.0135	CcSEcCtD
Treprostinil—Dermatitis—Metformin—polycystic ovary syndrome	0.00142	0.0135	CcSEcCtD
Treprostinil—Headache—Metformin—polycystic ovary syndrome	0.00142	0.0134	CcSEcCtD
Treprostinil—Nausea—Metformin—polycystic ovary syndrome	0.00134	0.0127	CcSEcCtD
Treprostinil—PPARD—Metabolism—SRD5A1—polycystic ovary syndrome	0.000657	0.000879	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000647	0.000865	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000638	0.000853	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000634	0.000848	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000632	0.000845	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000632	0.000845	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00063	0.000842	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—STAR—polycystic ovary syndrome	0.000627	0.000838	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000627	0.000838	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000627	0.000838	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00062	0.000829	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000619	0.000828	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000617	0.000825	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000613	0.000819	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000611	0.000817	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000609	0.000814	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000608	0.000812	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—GNAS—polycystic ovary syndrome	0.000601	0.000804	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0006	0.000802	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000595	0.000795	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000591	0.00079	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000587	0.000785	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000582	0.000777	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000582	0.000777	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.00058	0.000776	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000574	0.000767	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00056	0.000749	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMMR—polycystic ovary syndrome	0.000559	0.000747	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000558	0.000746	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—GNAS—polycystic ovary syndrome	0.000554	0.00074	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000547	0.000732	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000544	0.000727	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000544	0.000727	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000534	0.000714	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HSD3B1—polycystic ovary syndrome	0.000533	0.000713	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000528	0.000706	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—polycystic ovary syndrome	0.000527	0.000705	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000527	0.000705	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000514	0.000687	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—YAP1—polycystic ovary syndrome	0.000509	0.00068	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000508	0.000679	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000501	0.000669	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.0005	0.000668	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000498	0.000666	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000495	0.000662	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000494	0.00066	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000493	0.000658	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000491	0.000657	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LHB—polycystic ovary syndrome	0.000486	0.00065	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HSD3B2—polycystic ovary syndrome	0.000475	0.000635	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000473	0.000632	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000467	0.000625	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000463	0.000618	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKR1C1—polycystic ovary syndrome	0.00046	0.000615	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000456	0.000609	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000453	0.000606	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000453	0.000605	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00045	0.000601	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000449	0.000601	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000449	0.0006	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PGR—polycystic ovary syndrome	0.000444	0.000594	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000441	0.00059	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000435	0.000582	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000435	0.000581	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000426	0.000569	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SULT2A1—polycystic ovary syndrome	0.000424	0.000566	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000423	0.000566	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000417	0.000557	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000414	0.000553	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FST—polycystic ovary syndrome	0.000412	0.000551	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000411	0.000549	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RRM2—polycystic ovary syndrome	0.00041	0.000548	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00041	0.000548	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00041	0.000548	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000407	0.000544	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000405	0.000541	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000405	0.000541	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LHB—polycystic ovary syndrome	0.000402	0.000538	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.0004	0.000535	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—YAP1—polycystic ovary syndrome	0.000395	0.000529	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000393	0.000526	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF1—polycystic ovary syndrome	0.00039	0.000521	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000389	0.00052	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT2—polycystic ovary syndrome	0.000389	0.00052	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000381	0.000509	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00038	0.000508	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NAMPT—polycystic ovary syndrome	0.00038	0.000508	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FST—polycystic ovary syndrome	0.000379	0.000507	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000378	0.000505	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000377	0.000504	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SCT—polycystic ovary syndrome	0.000377	0.000504	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP11A1—polycystic ovary syndrome	0.000375	0.000502	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000375	0.000501	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000374	0.000499	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000374	0.000499	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000373	0.000498	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000372	0.000498	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LHB—polycystic ovary syndrome	0.00037	0.000495	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00037	0.000495	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000367	0.000491	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000362	0.000484	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00036	0.000481	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF1—polycystic ovary syndrome	0.000358	0.000479	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT2—polycystic ovary syndrome	0.000358	0.000479	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKR1C3—polycystic ovary syndrome	0.000354	0.000474	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000354	0.000473	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000351	0.000469	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000351	0.000469	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00035	0.000468	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP17A1—polycystic ovary syndrome	0.000349	0.000466	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SCT—polycystic ovary syndrome	0.000347	0.000464	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AR—polycystic ovary syndrome	0.000345	0.000462	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000345	0.000461	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000343	0.000458	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00034	0.000455	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000331	0.000443	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000327	0.000437	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000325	0.000435	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000325	0.000434	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000323	0.000431	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000323	0.000431	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00032	0.000428	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000318	0.000425	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000313	0.000419	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INSR—polycystic ovary syndrome	0.000309	0.000413	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NCOR1—polycystic ovary syndrome	0.000302	0.000404	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TH—polycystic ovary syndrome	0.000302	0.000404	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000301	0.000403	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000297	0.000397	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000297	0.000397	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A4—polycystic ovary syndrome	0.000294	0.000393	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000293	0.000392	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000289	0.000386	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PGR—polycystic ovary syndrome	0.000286	0.000382	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INSR—polycystic ovary syndrome	0.000284	0.00038	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000283	0.000379	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR3C1—polycystic ovary syndrome	0.000279	0.000373	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP19A1—polycystic ovary syndrome	0.000276	0.000369	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00027	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000266	0.000355	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000266	0.000355	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000266	0.000355	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PGR—polycystic ovary syndrome	0.000263	0.000352	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000262	0.00035	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000258	0.000345	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000256	0.000342	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—polycystic ovary syndrome	0.000254	0.00034	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000253	0.000339	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000247	0.00033	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GNAS—polycystic ovary syndrome	0.000246	0.000329	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000246	0.000329	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000244	0.000327	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000244	0.000327	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000241	0.000322	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000236	0.000315	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NCOR1—polycystic ovary syndrome	0.000235	0.000314	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—polycystic ovary syndrome	0.000234	0.000313	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000234	0.000313	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000233	0.000312	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000232	0.000311	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRL—polycystic ovary syndrome	0.000232	0.00031	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.00023	0.000308	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000227	0.000304	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000226	0.000303	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000223	0.000299	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000297	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00022	0.000294	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00022	0.000293	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—polycystic ovary syndrome	0.000216	0.000289	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000215	0.000288	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000215	0.000287	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000214	0.000286	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRL—polycystic ovary syndrome	0.000213	0.000285	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.00021	0.000281	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.00021	0.000281	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000208	0.000278	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—polycystic ovary syndrome	0.000207	0.000277	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000206	0.000275	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000204	0.000273	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000202	0.000271	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000196	0.000262	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000195	0.000261	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000195	0.000261	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000194	0.00026	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000191	0.000256	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000191	0.000255	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000188	0.000251	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000179	0.000239	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000179	0.000239	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000175	0.000235	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000169	0.000226	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—polycystic ovary syndrome	0.000168	0.000225	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000166	0.000222	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000166	0.000222	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—polycystic ovary syndrome	0.000166	0.000222	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INS—polycystic ovary syndrome	0.000165	0.000221	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000163	0.000218	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00016	0.000214	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—polycystic ovary syndrome	0.00016	0.000214	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000158	0.000211	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00015	0.000201	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—polycystic ovary syndrome	0.000147	0.000197	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000143	0.000191	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000139	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—polycystic ovary syndrome	0.000137	0.000184	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INS—polycystic ovary syndrome	0.000137	0.000183	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000132	0.000177	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000132	0.000177	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000132	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000131	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—polycystic ovary syndrome	0.000126	0.000169	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000126	0.000169	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INS—polycystic ovary syndrome	0.000126	0.000168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000125	0.000168	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000125	0.000167	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000122	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000121	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000115	0.000154	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000112	0.00015	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000107	0.000143	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000106	0.000142	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000101	0.000135	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.0001	0.000134	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	9.78e-05	0.000131	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	9.56e-05	0.000128	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—polycystic ovary syndrome	9.29e-05	0.000124	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	9.26e-05	0.000124	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.63e-05	0.000115	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	8.52e-05	0.000114	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	8.25e-05	0.00011	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.95e-05	0.000106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.94e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	7.64e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.6e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	7.54e-05	0.000101	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.49e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	7.13e-05	9.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	7.01e-05	9.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TH—polycystic ovary syndrome	6.07e-05	8.11e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—polycystic ovary syndrome	5.97e-05	7.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.9e-05	7.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.55e-05	7.42e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—polycystic ovary syndrome	5.49e-05	7.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.95e-05	6.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.72e-05	6.31e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.47e-05	5.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	4.17e-05	5.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.38e-05	4.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.34e-05	4.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.32e-05	4.43e-05	CbGpPWpGaD
